Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1998, p. 281-283, Vol. 36, No. 1
Departments of Medicine and Clinical
Biochemistry, The Toronto Hospital, Mount Sinai Hospital, and the
University of Toronto, Toronto, Ontario, Canada
Received 23 June 1997/Returned for modification 26 August
1997/Accepted 21 October 1997
Universal prophylaxis with oral ganciclovir is not cost-effective
for the prevention of cytomegalovirus (CMV) disease in human immunodeficiency virus infection. For a preemptive strategy to be
considered, patients at highest risk for CMV disease need to be easily
and accurately identified. In this study, the sensitivity, specificity,
positive predictive value, and negative predictive value of a single
CMV DNA PCR assay for the subsequent development of CMV disease were
0.75, 0.89, 0.75, and 0.89, respectively.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Long-Term Predictive Value of a Single Cytomegalovirus (CMV) DNA
PCR Assay for CMV Disease in Human Immunodeficiency
Virus-Infected Patients
*
Corresponding author. Mailing address: The Toronto
Hospital, Eaton Wing, Ground Floor, Room 219, 200 Elizabeth St.,
Toronto, Ontario, Canada M5G 2C4. Phone: (416) 340-3871. Fax: (416)
595-5826. E-mail: swalmsley{at}torhosp.toronto.on.ca.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»